The Beauty Health Company - Class A Common Stock (SKIN)
1.3450
+0.0550 (4.26%)
NASDAQ · Last Trade: Nov 7th, 12:42 PM EST
Detailed Quote
Previous Close
1.290
Open
1.370
Bid
1.340
Ask
1.350
Day's Range
1.330 - 1.740
52 Week Range
0.7800 - 2.690
Volume
2,869,325
Market Cap
202.55M
PE Ratio (TTM)
-5.380
EPS (TTM)
-0.3
Dividend & Yield
N/A (N/A)
1 Month Average Volume
1,095,667
Chart
About The Beauty Health Company - Class A Common Stock (SKIN)
The Beauty Health Co. is a dynamic company specializing in innovative skincare solutions and aesthetic technologies. Focused on enhancing beauty and wellness, the company develops and markets unique products and treatment systems that cater to both professional and consumer markets. By leveraging advanced science and cutting-edge techniques, The Beauty Health Co. aims to address various skincare needs, promoting healthier skin and boosting confidence among its users. The company's commitment to quality and innovation positions it as a leader in the rapidly evolving beauty industry. Read More
Skincare company BeautyHealth (NASDAQ:SKIN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 10.3% year on year to $70.66 million. The company’s full-year revenue guidance of $296.5 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP loss of $0.09 per share was in line with analysts’ consensus estimates.
Skincare company BeautyHealth (NASDAQ:SKIN) reported revenue ahead of Wall Streets expectations in Q3 CY2025, but sales fell by 10.3% year on year to $70.7 million. The company’s full-year revenue guidance of $296.5 million at the midpoint came in 0.8% above analysts’ estimates. Its GAAP loss of $0.09 per share was in line with analysts’ consensus estimates.
LONG BEACH, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ: SKIN) (“BeautyHealth” or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the third quarter ended September 30, 2025 (“Q3 2025”).
Shares of skincare company BeautyHealth (NASDAQ:SKIN)
fell 7.4% in the afternoon session after investor concern grew ahead of its upcoming third-quarter 2025 earnings report, following the release of negative analyst estimates. Analysts projected that the company's revenue would fall by 13.29% compared to the previous year, landing at $68.33 million. Furthermore, estimates pointed to a loss per share of $0.083. These forecasts suggested potential financial weakness for the company, which likely led to the negative reaction from investors before the official results were announced.
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains.
This unpredictability can shake out even the most experienced investors.
A number of stocks jumped in the afternoon session after optimism surged over a potential trade truce between the U.S. and China. Reports of progress in trade negotiations ahead of a scheduled meeting between the two nations' presidents fueled investor confidence. An agreement would likely ease trade tensions and reduce or remove tariffs that have created economic uncertainty and higher costs for many multinational corporations. Also, optimism improved on expectations that the Federal Reserve will cut interest rates later in the week, especially after recent data showed inflation wasn't heating up as much as expected.
Simply put, good news on trade, and the promise of lower borrowing costs created a powerful rally.
Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of The Beauty Health Company (NASDAQ: SKIN) breached their fiduciary duties to shareholders.
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names.
But with less stability and fewer resources than their bigger counterparts, these companies face steeper challenges in scaling their businesses.
LONG BEACH, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report third quarter 2025 financial results after market close on Thursday, November 6, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at personal care stocks, starting with BeautyHealth (NASDAQ:SKIN).
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at personal care stocks, starting with USANA (NYSE:USNA).
Wall Street has set ambitious price targets for the stocks in this article.
While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
A number of stocks fell in the afternoon session after signs of weakening consumer health and a cautious outlook for the upcoming holiday season emerged.
Shares of skincare company BeautyHealth (NASDAQ:SKIN)
fell 5.5% in the afternoon session after TD Cowen raised its price target on the stock to $2.50 from $2.00 but maintained its 'Hold' rating.
Generating cash is essential for any business, but not all cash-rich companies are great investments.
Some produce plenty of cash but fail to allocate it effectively, leading to missed opportunities.
Shares of skincare company BeautyHealth (NASDAQ:SKIN)
fell 7.8% in the morning session after a key competitor, Waldencast, announced it received FDA approval for its Obagi saypha MagIQ injectable hyaluronic acid gel.
